Table 2.
Impact Factors* for Publications Resulting from Abstracts Submitted to the 2009 SGIM Annual Meeting
| Variable | n | Median impact factor | p § | |
|---|---|---|---|---|
| Site | Academic | 268 | 2.8 | 0.63 |
| Community | 6 | 2.5 | ||
| Topic | VA-based research | 11 | 3.0 | 0.007 |
| Health disparities/vulnerable populations | 37 | 3.2 | ||
| Medical education | 42 | 2.6 | ||
| Organization of care and chronic disease management | 31 | 2.8 | ||
| Clinical epidemiology/health care effectiveness research | 28 | 2.8 | ||
| Quality of care/patient safety | 25 | 3.9 | ||
| Aging/geriatrics/end of life | 23 | 3.9 | ||
| Preventive medicine | 12 | 3.9 | ||
| Mental health/substance abuse | 21 | 3.0 | ||
| Clinical decision-making and economic analysis | 11 | 3.1 | ||
| Women’s health | 10 | 2.8 | ||
| Cancer research | 5 | 19.0 | ||
| Global health/preparedness | 4 | 1.3 | ||
| Other† | 14 | 3.9 | ||
| Number of study sites | Single site | 95 | 2.6 | 0.002 |
| Multicenter, USA | 173 | 3.2 | ||
| Multicenter, international | 6 | 1.5 | ||
| Study design | Other‡ | 242 | 2.8 | 0.008 |
| Randomized controlled trial | 26 | 3.9 | ||
| Systematic review/meta-analysis | 5 | 8.2 | ||
| Sample size | ≤50 | 31 | 2.3 | 0.002 |
| 51–100 | 29 | 2.1 | ||
| 101–250 | 43 | 3.4 | ||
| 251–500 | 45 | 3.1 | ||
| 501–2000 | 43 | 3.3 | ||
| >2000 | 74 | 3.2 | ||
| Unknown | 9 | 2.4 | ||
| Abstract result | Negative | 115 | 2.8 | 0.05 |
| Positive | 134 | 3.3 | ||
| Not applicable | 25 | 2.6 |
*The impact factor was extracted from the year the article was published
†“Other” topics include health policy/advocacy/social justice, hospital-based medicine, medical humanities and ethics, personal/professional development, and research methods
‡“Other” study designs were defined as non-experimental studies, including observational, case–control, and qualitative studies
§Nonparametric analysis of variance (Kruskal–Wallis) test